Exploration of Ethical Review Disputes and Regulatory Pathways of Off-label Drug Use

The ethical risks of off-label clinical use of drugs include many risks, incomplete laws and regulations, difficulties in risk-benefit assessment, and challenges in managing conflict of interest management and obtaining informed consent. There are no clear regulations in China that require ethics co...

Full description

Saved in:
Bibliographic Details
Main Authors: Xuelian TANG, Jue WU, Xiaoyan LI, Jiyin ZHOU
Format: Article
Language:Chinese
Published: Editorial Office of Medicine and Philosophy 2025-02-01
Series:Yixue yu zhexue
Subjects:
Online Access:https://yizhe.dmu.edu.cn/article/doi/10.12014/j.issn.1002-0772.2025.04.06
Tags: Add Tag
No Tags, Be the first to tag this record!